The analysis revealed that subjects with combined variant GSTO1*A/A (GSTO1*A140D; D/D) and GSTO2*G/G (GSTO2*N142D; D/D) genotypes had a higher risk of developing cancer. This evidence concerns the gene GSTO2 and cancer.